30.04.2014 • NewsDede WillamsPharmaPharmaceuticals

Sanofi Said Eyeing Drug Divestments of Over $7 Billion

French pharmaceutical producer Sanofi is looking to sell a portfolio of mature drugs that could fetch between $7 billion and $8 billion, the news agency Reuters said, quoting unnamed sources.

The drugmaker, believed to working with Evercore Partners, is said to have contacted potential buyers.

The drugs for sale would include treatments for high blood pressure and cardio-metabolic diseases and have roughly $3.7 billion in combined annual revenue, a source told the news agency, adding that the portfolio could fetch up to two times that amount.

Generic drugmakers and specialty pharmaceutical companies are seen as logical buyers for the Sanofi drug portfolio.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.